Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21

Cholangiocarcinoma (CC) has a poor prognosis and different driver genes depending on the site of onset. Intrahepatic CC is the second‐most common liver cancer after hepatocellular carcinoma, and novel therapeutic targets are urgently needed. The present study was conducted to identify novel therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Etsushi, Matsubara, Tsutomu, Daikoku, Atsuko, Deguchi, Sanae, Kinoshita, Masahiko, Yuasa, Hideto, Urushima, Hayato, Odagiri, Naoshi, Motoyama, Hiroyuki, Kotani, Kohei, Kozuka, Ritsuzo, Hagihara, Atsushi, Fujii, Hideki, Uchida‐Kobayashi, Sawako, Tanaka, Shogo, Takemura, Shigekazu, Iwaisako, Keiko, Enomoto, Masaru, Taguchi, Y. H., Tamori, Akihiro, Kubo, Shoji, Ikeda, Kazuo, Kawada, Norifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714377/
https://www.ncbi.nlm.nih.gov/pubmed/36114826
http://dx.doi.org/10.1002/2211-5463.13489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714377/
https://www.ncbi.nlm.nih.gov/pubmed/36114826
http://dx.doi.org/10.1002/2211-5463.13489

Ejemplares similares